Previous 10 | Next 10 |
BOCA RATON, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal ...
BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced...
Why Penny Stocks Investors Are Watching These 3 Small-Caps Finding the best penny stocks to buy is a mixture of strategy and research. And, one metric that some penny stocks investors use is to find out what top investors are buying. This can be a great strategy to utilize, however ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in AzurRx Biopharma (NASDAQ: AZRX ) are seeing impressive gains. Indeed, AZRX stock is currently more than 30% higher today, trading on extremely heavy volume. More than 103 million sha...
Gainers: PharmaCyte Biotech (NASDAQ:PMCB) +118%. Virpax Pharmaceuticals (NASDAQ:VRPX) +59%. SGOCO Group (NASDAQ:SGOC) +53%. AzurRx BioPharma (NASDAQ:AZRX) +30%. NRx Pharmaceuticals (NASDAQ:NRXP) +26%. Standard Lithium (NYSE:SLI) +21%. ESSA Pharma (NASDAQ:EPIX) +15%. Agrify (NASDAQ:AGFY) +17%....
MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpoints Study data indicates clinically meaningful improvement in coefficient of fat absorption (CFA) primary endpoint 20-patient study suggests combination therapy ma...
BOCA RATON, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced the ...
BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) ( NASDAQ: AZRX ), a company specializing in the development of targeted non-systemic, therapies for gastrointestinal (GI) diseases, today announced the...
BOCA RATON, Fla., Aug. 12, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma , Inc. (“AzurRx” or the “Company”) ( NASDAQ: AZRX ), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announce...
BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma , Inc. (“AzurRx” or the “Company”) ( NASDAQ: AZRX ), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) disease...
News, Short Squeeze, Breakout and More Instantly...
AzurRx BioPharma Inc. Company Name:
AZRX Stock Symbol:
NASDAQ Market:
AzurRx BioPharma Inc. Website:
BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (G...
Why Investors Are Watching These 3 Penny Stocks Right Now There are plenty of ways to find the best penny stocks to buy right now. And, one method that many penny stocks investors use is looking at what top investors are buying alongside other metrics. While this can be a good strat...
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastroint...